Stelara 90 MG/ML syringeml
Ended Awarded Last action
- Contract number
- SPE2DR26FCFA0
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,584
Award facts
- Contract value 100% obligated
- $16,584.13 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a $16,584.13 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Stelara 90 mg/ml syringes. The delivery order, effective December 3, 2025, with an ultimate completion date of December 24, 2025, contains no set-aside designation and represents a competitively awarded purchase under the company's existing contract authority. DMS Pharmaceutical Group, registered in the System for Award Management since 2001, serves as a critical supplier within the federal pharmaceutical supply chain and maintains established performance across multiple therapeutic categories supporting Department of Defense medical operations.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (IDC) designated SPE2DR, awarded November 13, 2025, under the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative. The underlying IDC carries a $499.999 billion ceiling value through December 31, 2036, and positions DMS Pharmaceutical Group as a regional prime vendor contractor within the broader $30.3 billion PPV-G GEN V acquisition strategy. This structure enables the Defense Logistics Agency to issue firm fixed-price delivery orders for pharmaceutical products, including branded and generic prescription drugs, biologics, and medical consumables, to support the recurring medical supply needs of Department of Defense healthcare facilities worldwide.
Quick answers
Who was awarded contract SPE2DR26FCFA0?
SPE2DR26FCFA0 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 3, 2025.
How much is contract SPE2DR26FCFA0 worth?
The government has obligated $16,584 on SPE2DR26FCFA0.
Is contract SPE2DR26FCFA0 an order under another contract?
Yes. SPE2DR26FCFA0 is a delivery order under SPE2DR25D9130, an indefinite delivery contract.
Was contract SPE2DR26FCFA0 competed?
The extent of competition for SPE2DR26FCFA0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award